Paxlovid Covid-19 Treatment

Paxlovid is an oral antiviral medication that may be used to help prevent symptoms requiring hospitalization in patients with Covid-19.

What is Paxlovid and How Does it Work? 

Pfizer’s FDA authorized Covid pill, Paxlovid is an oral antiviral pill that works by stopping the viral replication process of the SARS-CoV-2 virus. This reduces a person’s viral load and lessens the severity of their symptoms. Paxlovid can reduce the risk of hospitalization by 89%, as demonstrated in one clinical trial. Paxlovid is effective against the Omicron variant of Covid-19 when taken within five days of the start of symptoms.

A table with a number of questions on it
A man holding a glass jar filled with white pills

Who is Eligible to Receive Paxlovid? 

You may qualify if:

  • A PCR or rapid antigen test has confirmed that you’re COVID-19 positive
  • You’ve been experiencing mild to moderate COVID symptoms for five days or less
  • You’re considered to be at high risk for COVID-related complications

How It Works

Book a virtual appointment from anywhere.

Meet with a provider from your smartphone or computer.

Get a prescription called in, and pick it up at your local pharmacy.

Order Medication

Returning customer? You can login here or continue as a guest checkout

  • Have you used Drip Hydration before?*
  • Hidden
    MM slash DD slash YYYY
  • Hidden
  • Hidden
  • Hidden
    **"Please do not provide any personal health info, only general info
  • $0.00

Frequently Asked Questions

Is molnupiravir FDA approved?

Is molnupiravir safe?

One stage 2 clinical trial found that molnupiravir is both effective and well-tolerated, meaning that there were few reported side effects. Fewer than 50% of study participants reported side effects in one study. The same study found that of these reports, 93% of side effects were mild.

Are there any FDA-approved pills for COVID-19?

Can people who have been vaccinated get the COVID-19 pill?

How effective are COVID-19 pills in preventing severe disease?

The Pfizer COVID-19 pill (Paxlovid) has been shown to reduce the risk of COVID-related hospitalization or death by 89%, while the Merck COVID-19 pill has been shown to reduce the risk of COVID-related hospitalization or death by 30%. The COVID-19 pill is not a substitute for the COVID-19 vaccine. Vaccinated people who take these COVID medications will likely have even better recovery outcomes than those who are unvaccinated.